Bromide

Bromide

SCHEMBL397402

Br.CC(C)[Zn]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402385 0.93
Hydrochloric Acid SCHEMBL395005 0.86
Iodide SCHEMBL394769 0.86
Bromide SCHEMBL643183 0.68
Isobutane SCHEMBL28999947 0.68
Isobutane SCHEMBL28999929 0.68 ALDH1A1 (0.43)
Isobutane SCHEMBL3368265 0.68
SCHEMBL954969 0.67
SCHEMBL953793 0.67
SCHEMBL955306 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115724739-A Resorcinol carboxylate metal complex, eutectic crystal or salt, and preparation method and application thereof 山东特珐曼药业有限公司 2023-03-03 CN claimed
CN-115626897-A Preparation method of 5-amino-4, 6-diisopropyl pyrimidine 常州佳德医药科技有限公司 2023-01-20 CN claimed
EP-3162786-B1 METHOD FOR PRODUCING 4-ISOPROPYL-3-METHYLPHENOL OSAKA KASEI CO LTD (JP) 2019-08-28 EP claimed
US-10252964-B2 Producing method for 4-isopropyl-3-methylphenol OSAKA KASEI CO., LTD. (JP) 2019-04-09 US claimed
US-20170129836-A1 PRODUCING METHOD FOR 4-ISOPROPYL-3-METHYLPHENOL OSAKA KASEI CO., LTD. (JP) 2017-05-11 US claimed
EP-3162786-A1 METHOD FOR PRODUCING 4-ISOPROPYL-3-METHYLPHENOL Osaka Kasei Co., Ltd. (JP) 2017-05-03 EP claimed
US-20260022118-A1 HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS UNIV TEXAS (US) 2026-01-22 US disclosed
US-20250381187-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2025-12-18 US disclosed
US-12440491-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2025-10-14 US disclosed
US-12404241-B2 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith CELGENE CORPORATION (US) 2025-09-02 US disclosed
EP-3268129-B1 OLEFIN OLIGOMERISATION PROCESS WITH A CATALYST COMPRISING A CHROMIUM COMPLEX WITH A PHOSPHACYCLE-CONTAINING LIGAND DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-18 EP disclosed
CN-119654322-A TYK2 inhibitors 渤健马萨诸塞州股份有限公司 2025-03-18 CN disclosed
CN-119219606-A Substituted 3- ((3-aminophenyl) amino) piperidine-2, 6-dione compounds, compositions thereof, and methods of treatment using the same 细胞基因公司 2024-12-31 CN disclosed
EP-2035436-A1 FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS UCB Pharma S.A. (BE) 2009-03-18 EP disclosed
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed
WO-2008001076-A1 FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2008-01-03 WO disclosed
US-20070203159-A1 Purine compounds UNIVERSITETET I OLSO (NO) 2007-08-30 US disclosed
EP-0013082-B1 PROCESS FOR PRODUCING STEROID COMPOUNDS HAVING AN OXOGROUP IN THE SIDE CHAIN TEIJIN LIMITED (JP) 1982-12-15 EP disclosed
US-4298537-A Process for producing steroid compounds having an oxo group in the side chain TEIJIN LIMITED (JP) 1981-11-03 US disclosed
EP-0013082-A1 Process for producing steroid compounds having an oxogroup in the side chain TEIJIN LIMITED (JP) 1980-07-09 EP disclosed